Royalty Pharma plc RPD.F Stock
Royalty Pharma plc Price Chart
Royalty Pharma plc RPD.F Financial and Trading Overview
| Royalty Pharma plc stock price | 26.48 EUR |
| Previous Close | 26.63 EUR |
| Open | 26.89 EUR |
| Bid | 26.98 EUR x N/A |
| Ask | 27.65 EUR x N/A |
| Day's Range | 26.89 - 26.98 EUR |
| 52 Week Range | 26.57 - 44 EUR |
| Volume | 125 EUR |
| Avg. Volume | 23 EUR |
| Market Cap | 12.4B EUR |
| Beta (5Y Monthly) | 0.386824 |
| PE Ratio (TTM) | 52.901962 |
| EPS (TTM) | 2.36 EUR |
| Forward Dividend & Yield | 0.73 (2.77%) |
| Ex-Dividend Date | August 17, 2023 |
| 1y Target Est | 51.43 EUR |
RPD.F Valuation Measures
| Enterprise Value | 20.44B EUR |
| Trailing P/E | 52.901962 |
| Forward P/E | 8.875 |
| PEG Ratio (5 yr expected) | 1.18 |
| Price/Sales (ttm) | 5.2496877 |
| Price/Book (mrq) | 1.9343275 |
| Enterprise Value/Revenue | 8.654 |
| Enterprise Value/EBITDA | 19.351 |
Trading Information
Royalty Pharma plc Stock Price History
| Beta (5Y Monthly) | 0.386824 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 44 EUR |
| 52 Week Low | 26.57 EUR |
| 50-Day Moving Average | 27.81 EUR |
| 200-Day Moving Average | 33.22 EUR |
RPD.F Share Statistics
| Avg. Volume (3 month) | 23 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 448.93M |
| Float | 385.45M |
| Short Ratio | N/A |
| % Held by Insiders | 3.83% |
| % Held by Institutions | 68.98% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.78 |
| Trailing Annual Dividend Yield | 2.92% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.4182 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 10.79% |
| Operating Margin (ttm) | 44.60% |
| Gross Margin | 58.75% |
| EBITDA Margin | 44.72% |
Management Effectiveness
| Return on Assets (ttm) | 3.77% |
| Return on Equity (ttm) | 4.65% |
Income Statement
| Revenue (ttm) | 2.36B EUR |
| Revenue Per Share (ttm) | 5.31 EUR |
| Quarterly Revenue Growth (yoy) | 0.40% |
| Gross Profit (ttm) | 1.33B EUR |
| EBITDA | 1.06B EUR |
| Net Income Avi to Common (ttm) | 254.95M EUR |
| Diluted EPS (ttm) | 0.51 |
| Quarterly Earnings Growth (yoy) | -25.19% |
Balance Sheet
| Total Cash (mrq) | 2.18B EUR |
| Total Cash Per Share (mrq) | 4.85 EUR |
| Total Debt (mrq) | 7.13B EUR |
| Total Debt/Equity (mrq) | 72.62 EUR |
| Current Ratio (mrq) | 2.52 |
| Book Value Per Share (mrq) | 13.948 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.75B EUR |
| Levered Free Cash Flow (ttm) | -1643629184 EUR |
Profile of Royalty Pharma plc
| Country | Germany |
| State | NY |
| City | New York |
| Address | 110 East 59th Street |
| ZIP | 10022 |
| Phone | 212 883 0200 |
| Website | https://www.royaltypharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Q&A For Royalty Pharma plc Stock
What is a current RPD.F stock price?
Royalty Pharma plc RPD.F stock price today per share is 26.48 EUR.
How to purchase Royalty Pharma plc stock?
You can buy RPD.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Royalty Pharma plc?
The stock symbol or ticker of Royalty Pharma plc is RPD.F.
Which industry does the Royalty Pharma plc company belong to?
The Royalty Pharma plc industry is Biotechnology.
How many shares does Royalty Pharma plc have in circulation?
The max supply of Royalty Pharma plc shares is 593.57M.
What is Royalty Pharma plc Price to Earnings Ratio (PE Ratio)?
Royalty Pharma plc PE Ratio is 11.22033900 now.
What was Royalty Pharma plc earnings per share over the trailing 12 months (TTM)?
Royalty Pharma plc EPS is 2.36 EUR over the trailing 12 months.
Which sector does the Royalty Pharma plc company belong to?
The Royalty Pharma plc sector is Healthcare.